Breast cancer survival in African-American women by hormone receptor subtypes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2015-08-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-015-3528-7PMID 26250393PMCID PMC6043784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age at cancer diagnosis for blacks compared with whites in the United States.

  2015influential reference
• Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system.

  2015influential reference
• Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

  2015cited by this paper
• Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study

  2015cited by this paper
• Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

  2014cited by this paper
• Breast cancer disparities: high-risk breast cancer and African ancestry.

  2014cited by this paper
• Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression

  2014cited by this paper
• US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

  2014cited by this paper
• Breast cancer statistics, 2013

  2014cited by this paper
• Trends in Breast Cancer Stage and Mortality in Michigan (1992–2009) by Race, Socioeconomic Status, and Area Healthcare Resources

  2013cited by this paper
• Individual and Neighborhood Socioeconomic Status and Healthcare Resources in Relation to Black-White Breast Cancer Survival Disparities

  2013cited by this paper
• Breast Cancer Statistics

  2013cited by this paper
• Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status

  2013cited by this paper
• Triple-negative breast cancer: epidemiological considerations and recommendations.

  2012cited by this paper
• Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer

  2012cited by this paper
• Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit.

  2010cited by this paper
• Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

  2010cited by this paper
• The association of metabolic syndrome with triple-negative breast cancer

  2010cited by this paper
• Pharmacotherapy of triple-negative breast cancer

  2009cited by this paper
• Treatment outcomes and clinicopathologic characteristics of triple‐negative breast cancer patients who received platinum‐containing chemotherapy

  2009cited by this paper
• Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race

  2009cited by this paper
• Triple‐negative/basal‐like breast cancer: review

  2009cited by this paper
• Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population

  2008cited by this paper
• The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor‐negative, invasive breast cancer: The California Cancer Registry, 1999–2004

  2008cited by this paper
• p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes.

  2008cited by this paper
• Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

  2008cited by this paper
• Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

  2008cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

  2008cited by this paper
• Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women.

  2008cited by this paper
• Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment

  2008cited by this paper
• Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

  2007cited by this paper
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

  2007cited by this paper
• Triple negative tumours: a critical review

  2007cited by this paper
• 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

  2007cited by this paper
• HER2 and response to paclitaxel in node-positive breast cancer.

  2007cited by this paper
• Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

  2007cited by this paper
• Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

  2006cited by this paper
• Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Trends in Breast Cancer by Race and Ethnicity: Update 2006

  2006cited by this paper
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project

  2005cited by this paper
• Comorbidity and survival disparities among black and white patients with breast cancer.

  2005cited by this paper
• Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Differences in breast cancer stage, treatment, and survival by race and ethnicity.

  2003cited by this paper
• Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

  2003cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Race, socioeconomic status, and breast cancer treatment and survival.

  2002cited by this paper
• Race, socioeconomic status, and breast carcinoma in the U.S.

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Is race a poor prognostic factor in breast cancer?

  1999cited by this paper
• Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.

  1997cited by this paper

• Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis

  2026cites this paper
• Molecular subtypes of breast cancer in Jamaican women: high prevalence of triple-negative and HER2 + disease

  2026cites this paper
• Disparities in Breast Cancer Screening and Diagnosis Among Black Women: A Path Toward Equity.

  2025cites this paper
• Diagnostic potential of exosomal extracellular vesicles in oncology

  2024cites this paper
• The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes

  2024cites this paper
• Socioeconomic and racial disparities in survival for patients with stage IV cancer.

  2023cites this paper
• Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancers

  2021influential citation
• Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort

  2020cites this paper
• Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

  2019cites this paper
• Do breast quadrants explain racial disparities in breast cancer outcomes?

  2019cites this paper
• Asosiasi Triple Negative Breast Cancer (TNBC) Dengan Mutasi BRCA-1 Dan Etnisitas

  2019cites this paper
• Time to Clinical Follow-up after Abnormal Mammogram among African American and Hispanic Women

  2018cites this paper
• Overall Survival and Local Recurrence Among Breast Cancer Patients in Hospital Sultanah Nora Ismail Batu Pahat, 2007-2013

  2018cites this paper
• Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database

  2018cites this paper
• Breast cancer metastasis through the lympho-vascular system

  2018cites this paper
• Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites

  2017cites this paper
• Clinical Outcomes of Estrogen Negative-Progesterone Positive Invasive Breast Cancer, Retrospective Study

  2017cites this paper
• Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee

  2017cites this paper
• Race in Cancer Health Disparities Theme Issues Triple-Negative Breast Cancer , Stem Cells , and African Ancestry

  2017cites this paper
• Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe.

  2017cites this paper
• Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review

  2017cites this paper
• The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries

  2017cites this paper
• Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old

  2017cites this paper
• Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources

  2016cites this paper
• Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer

  2016cites this paper
• Stories of African American women who are long-term breast cancer survivors

  2016influential citation